Skip to content
homeHOME R&D Publications

Publications

Search

[Conference presentation]

"GLP-1/FGF21 dual agonism, Good things come in pairs"
Oral presentation (2019 NASH TAG)

Download

[Conference presentation]

"YH25724, a Novel Long-Acting GLP-1/FGF21 Dual Agonist, Exhibits Marked Anti-Fibrotic Effects in Different Experimental Model of Liver Fibrosis"
Poster (2019 EASL)

Download

[Conference presentation]

"YH25724, a Novel Long-Acting GLP-1/FGF21 Dual Agonist, Exhibits Marked Anti-Fibrotic Effects in a Rat Model of Established Thioacetamide-Induced Liver Fibrosis"
Poster (2018 AASLD)

Download

[Conference presentation]

"YH25724, a novel long-acting GLP-1/FGF21 dual agonist, induces body weight loss and improves glucose and lipid metabolism in obese diabetic monkeys"
Poster (2017 AASLD)

Download

[Conference presentation]

"YH25724, a novel long-acting GLP-1/FGF21 dual agonist lowers both NAFLD activity score and fibrosis stage in a diet-induced obese mouse model of biopsy-confirmed nonalcoholic steatohepatitis"
Oral presentation (2017 EASL)

Download

[Conference presentation]

"YH-Dual Agonist, a Novel Long-Acting GLP-1-Fc-FGF21 Provides More Potent, Sustained, Synergistic Glycemic Control and Weight Loss Compared with Mono-Fc in Animal Models"
Poster (2016 ADA)

Download

[Conference presentation]

"YH25724, a novel long-acting GLP-1/FGF21 dual agonist improves hepatic steatosis, inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) animal"
Poster (2016 AASLD)

Download